Literature DB >> 18847368

Oxidative stress, free radicals and bone remodeling.

Giuseppe Banfi1, Eugenio L Iorio, Massimiliano M Corsi.   

Abstract

Reactive oxygen species (ROS) are widely considered to be a causal factor in aging and in a number of pathological conditions, such as atherosclerosis, carcinogenesis and infarction. Their role in bone metabolism is dual, considering their effects under physiological or pathological conditions. Under physiological conditions, the production of ROS by osteoclasts helps accelerate destruction of calcified tissue, thus assisting in bone remodeling. In pathological conditions, when a bone fractures, e.g., radical generation is remarkably high. However, though the increases in osteoclastic activity and ROS production are linked in many skeletal pathologies, it remains to be clarified whether increased ROS production overwhelms antioxidant defenses, leaving the individual open to hyperoxidant stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18847368     DOI: 10.1515/CCLM.2008.302

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  76 in total

Review 1.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

Review 2.  Tea and bone health: steps forward in translational nutrition.

Authors:  Chwan-Li Shen; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

3.  Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.

Authors:  A M Tyagi; K Srivastava; J Kureel; A Kumar; A Raghuvanshi; D Yadav; R Maurya; A Goel; D Singh
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

4.  The protective effect of lycopene intake on bone loss in ovariectomized rats.

Authors:  Yuki Iimura; Umon Agata; Satoko Takeda; Yuki Kobayashi; Shigeki Yoshida; Ikuko Ezawa; Naomi Omi
Journal:  J Bone Miner Metab       Date:  2014-07-05       Impact factor: 2.626

5.  Dietary isoflavones and bone mineral density during midlife and the menopausal transition: cross-sectional and longitudinal results from the Study of Women's Health Across the Nation Phytoestrogen Study.

Authors:  Gail A Greendale; Chi-Hong Tseng; Weijuan Han; Mei-Hua Huang; Katherine Leung; Sybil Crawford; Ellen B Gold; L Elaine Waetjen; Arun S Karlamangla
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

6.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  PAMM: a redox regulatory protein that modulates osteoclast differentiation.

Authors:  Yan Xu; Leslie R Morse; Raquel Assed Bezerra da Silva; Paul R Odgren; Hajime Sasaki; Philip Stashenko; Ricardo A Battaglino
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

8.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

Review 9.  The role of homocysteine in bone remodeling.

Authors:  Thomas P Vacek; Anuradha Kalani; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

10.  Effect and mechanism of pyrroloquinoline quinone on anti-osteoporosis in Bmi-1 knockout mice-Anti-oxidant effect of pyrroloquinoline quinone.

Authors:  Yuanqing Huang; Ning Chen; Dengshun Miao
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.